Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-08 | Amended | $5,550,000 | $1,400,000 | Equity Only | 06b | SEC link |
| 2024-10-09 | New | $4,150,000 | $4,150,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jon A. Brilliant | Executive |
| Lynda Chin | Director |
| Ronan O'hagan | Director, Executive |